Mercer Global Advisors Inc Charles River Laboratories International, Inc. Transaction History
Mercer Global Advisors Inc
- $45.6 Billion
- Q3 2024
A detailed history of Mercer Global Advisors Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 4,358 shares of CRL stock, worth $846,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,358
Previous 4,031
8.11%
Holding current value
$846,280
Previous $832,000
3.13%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$988 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$726 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$414 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$377 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.88B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...